EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Immune Dysfunction in Medication-Related Osteonecrosis of the Jaw

Ilaria Roato iD, Rodolfo Mauceri iD, Vincenzo Notaro iD, Tullio Genova iD, Vittorio Fusco, Federico Mussano iD

International Journal of Molecular Sciences · 27.04.2023 · 24 (9) · 7948

DOI: 10.3390/ijms24097948 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 27.04.2023. Verfasst von Ilaria Roato und 5 weiteren Autor:innen. Beteiligte Einrichtung: CIR-Dental School, Department of Surgical Sciences, University of Turin, 10126 Turin, Italy. Hauptthemen laut MEDLINE: Bisphosphonate-Associated Osteonecrosis of the Jaw, Bone Density Conservation Agents, Respiratory Distress Syndrome. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 116 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CRT Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The pathogenesis of medication-related osteonecrosis of the jaw (MRONJ) is multifactorial and there is a substantial consensus on the role of antiresorptive drugs (ARDs), including bisphosphonates (BPs) and denosumab (Dmab), as one of the main determinants. The time exposure, cumulative dose and administration intensity of these drugs are critical parameters to be considered in the treatment of patients, as cancer patients show the highest incidence of MRONJ. BPs and Dmab have distinct mechanisms of action on bone, but they also exert different effects on immune subsets which interact with bone cells, thus contributing to the onset of MRONJ. Here, we summarized the main effects of ARDs on the different immune cell subsets, which consequently affect bone cells, particularly osteoclasts and osteoblasts. Data from animal models and MRONJ patients showed a deep interference of ARDs in modulating immune cells, even though a large part of the literature concerns the effects of BPs and there is a lack of data on Dmab, demonstrating the need to further studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bisphosphonate-Associated Osteonecrosis of the JawBone Density Conservation AgentsRespiratory Distress SyndromeHumansDenosumabDiphosphonates

Stichwörter der Autor:innen

antiresorptive drugimmune systemmedication-related osteonecrosis of the jawosteoblastosteoclast

Substanzen

DenosumabBone Density Conservation AgentsDiphosphonates

Autor:innen und Institutionen

  • CIR-Dental School, Department of Surgical Sciences, University of Turin, 10126 Turin, Italy.
  • Department of Surgical, Oncological and Oral Sciences, University of Palermo, 90133 Palermo, Italy.
  • Department of Life Sciences and Systems Biology, University of Torino, 10123 Torino, Italy.
  • Medical Oncology Unit, Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo, 15121 Alessandria, Italy.
  • Department of Integrated Research Activity and Innovation (DAIRI), Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo, 15121 Alessandria, Italy.

ORCID-Profile: Ilaria Roato, Rodolfo Mauceri, Vincenzo Notaro, Tullio Genova, Federico Mussano

Förderung

  • CRT Foundation

Zitieren

APA

Roato, I., Mauceri, R., Notaro, V., Genova, T., Fusco, V., & Mussano, F. (2023). Immune Dysfunction in Medication-Related Osteonecrosis of the Jaw. International Journal of Molecular Sciences, 24(9), 7948. https://doi.org/10.3390/ijms24097948

Vancouver

Roato I, Mauceri R, Notaro V, Genova T, Fusco V, Mussano F. Immune Dysfunction in Medication-Related Osteonecrosis of the Jaw. International Journal of Molecular Sciences. 2023;24(9):7948. doi:10.3390/ijms24097948

BibTeX
@article{Roato2023,
  author = {Roato, Ilaria and Mauceri, Rodolfo and Notaro, Vincenzo and Genova, Tullio and Fusco, Vittorio and Mussano, Federico},
  title = {Immune Dysfunction in Medication-Related Osteonecrosis of the Jaw},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {9},
  pages = {7948},
  doi = {10.3390/ijms24097948}
}
Kostenlos starten →